Skip to main content

Home/ health information/ Group items tagged REVIEW

Rss Feed Group items tagged

Filter: All | Bookmarks | Topics Simple Middle
Mike Jobs

Modern Hair Transplantation Surgery: What It Is All About? - 0 views

business-review-in.blogspot.in/...r-transplantation-surgery.html

hair transplant kolkata hair transplantation kolkata

shared by Mike Jobs on 16 Dec 13 - No Cached
  • Mike Jobs on 16 Dec 13
     
    Hair transplantation is a minimally invasive surgical intervention that requires removal of hair follicles from one region of the body and placing them on hair-deficient areas. It is a widely-used technique in U.S for treating hereditary-patterned baldness, especially in males. Aside scalp hair loss, it is possible to revive the lost hair on eyebrows, chest and eyelashes.
Garry Lee

Reviews about Botox and Juvederm at Look Younger MD - 0 views

www.slideshare.net/...uvederm-do-you-know-about-them

Botox Las Vegas ' Juvederm beauty skin aging

shared by Garry Lee on 06 Apr 14 - No Cached
  • Garry Lee on 06 Apr 14
     
    Did you ever thought about Botox or Juvederm? These effective procedures are followed by most of the people in Henderson and Las Vegas. I must say that these cosmetic procedures are really great. Most of the people are opting for it and it is really effective. So visit at Look Younger MD in Henderson and Las Vegas to know more.
  • Garry Lee on 06 Apr 14
     
    Did you ever thought about Botox or Juvederm? These effective procedures are followed by most of the people in Henderson and Las Vegas. I must say that these cosmetic procedures are really great. Most of the people are opting for it and it is really effective. So visit at Look Younger MD in Henderson and Las Vegas to know more.
Alex Parker

Boehringer's Pradaxa gets FDA approval for DVT, PE treatment - 1 views

regulatoryaffairs.pharmaceutical-business-review.com/...vt-pe-treatment-090414-4211375

Health treatment

shared by Alex Parker on 09 Apr 14 - No Cached
  • Alex Parker on 09 Apr 14
     
    Germany-based pharmaceutical firm Boehringer Ingelheim has received approval from the US Food and Drug Administration (FDA) for Pradaxa (dabigatran etexilate) to treat venous thromboembolism (VTE), which includes both deep venous thrombosis (DVT) and pulmonary embolism (PE).
Alex Parker

EMA announces final steps for its clinical-trial data policy - 1 views

processandproduction.pharmaceutical-business-review.com/...ial-data-policy-090414-4211660

Health treatment buy

shared by Alex Parker on 09 Apr 14 - No Cached
  • Alex Parker on 09 Apr 14
     
    EMA will launch a final round of targeted consultations with key stakeholders on its draft policy on proactive publication of and access to clinical-trial data at the beginning of May 2014.
Alex Parker

Evotec, Debiopharm to research and develop new cancer treatments - 1 views

contractresearch.pharmaceutical-business-review.com/...ncer-treatments-030414-4208083

health treatment

shared by Alex Parker on 04 Apr 14 - No Cached
  • Alex Parker on 04 Apr 14
     
    Germany based drug discovery firm Evotec has entered into a research collaboration and licensing deal with Swiss biopharmaceutical firm Debiopharm Group to research and develop new cancer treatments
Alex Parker

Tetraphase's eravacycline gets FDA fast track status - 1 views

regulatoryaffairs.pharmaceutical-business-review.com/...st-track-status-030414-4208894

health treatment

shared by Alex Parker on 04 Apr 14 - No Cached
  • Alex Parker on 04 Apr 14
     
    The US Food & Drug Administration (FDA) has granted fast track designations for both the intravenous (IV) and oral formulations of Tetraphase Pharmaceuticals' lead antibiotic candidate, eravacycline.
Alex Parker

Dainippon's Latuda gets approval in Canada to treat bipolar depression - 1 views

regulatoryaffairs.pharmaceutical-business-review.com/...olar-depression-040414-4209058

health treatment

shared by Alex Parker on 04 Apr 14 - No Cached
  • Alex Parker on 04 Apr 14
     
    Dainippon Sumitomo Pharma (DSP) has received approval from Health Canada for use of Latuda (lurasidone HCl) as monotherapy or as adjunctive therapy with lithium or valproate to treat depressive episodes associated with bipolar I disorder.
Alex Parker

PanOptica raises $45m to finance clinical development of anti-VEGF eye drop for wet AMD - 1 views

manufacturing.pharmaceutical-business-review.com/...rop-for-wet-amd-160414-4215489

Health

shared by Alex Parker on 16 Apr 14 - No Cached
  • Alex Parker on 16 Apr 14
     
    PanOptica has raised up to $45m in a Series B financing to fund the clinical program for its lead compound, PAN-90806, a pharmacologically unique small-molecule selective inhibitor of VEGF
Alex Parker

GlaxoSmithKline's Tanzeum gets FDA approval for type 2 diabetes treatment - 1 views

drugdelivery.pharmaceutical-business-review.com/...betes-treatment-160414-4215125

Health foods

shared by Alex Parker on 16 Apr 14 - No Cached
  • Alex Parker on 16 Apr 14
     
    GSK has received approval from FDA for its Tanzeum subcutaneous injection to improve glycemic control, along with diet and exercise, in adult patients with type 2 diabetes.
Alex Parker

Charles River acquires Galapagos' CRO services division - 1 views

contractresearch.pharmaceutical-business-review.com/...rvices-division-010414-4207101

treatment

shared by Alex Parker on 02 Apr 14 - No Cached
  • Alex Parker on 02 Apr 14
     
    Charles River Laboratories International (CRL) has completed the previously announced acquisition of the CRO services division of Galapagos (GLPGF), which includes both Argenta and BioFocus.
Alex Parker

RainTree launches new cloud-based analytics portal for pharmaceutical industry - 1 views

itsoftware.pharmaceutical-business-review.com/...utical-industry-160414-4215651

Health

shared by Alex Parker on 17 Apr 14 - No Cached
  • Alex Parker on 17 Apr 14
     
    RainTree Oncology Services and Information Builders have launched OncoExplorer, a new cloud-based analytics portal that offers unprecedented decision-support capabilities to pharmaceutical companies.
Alex Parker

DesignMedix gets $3m NIH grant to develop low-cost malaria drug - 1 views

drugdiscovery.pharmaceutical-business-review.com/...st-malaria-drug-160414-4215927

Health foods generic buy

shared by Alex Parker on 17 Apr 14 - No Cached
  • Alex Parker on 17 Apr 14
     
    US-based biotech startup DesignMedix has received a grant of $3m from the National Institutes of Health (NIH) to continue the development and manufacturing of a new anti-malarial drug.
Alex Parker

Valeant, Ackman sign deal to acquire Botox-maker Allergan for $45bn - 1 views

manufacturing.pharmaceutical-business-review.com/...lergan-for-45bn-230414-4218796

health treatment

shared by Alex Parker on 23 Apr 14 - No Cached
  • Alex Parker on 23 Apr 14
     
    PBR Staff Writer Published 23 April 2014 Canada-based Valeant Pharmaceuticals (Valeant) and activist investor Bill Ackman have revealed details of their offer to acquire Botox-maker Allergan, in a cash-and-stock deal that could be worth more than $45bn. Under the deal, Allergan investors would receive $48.30 in cash and 0.83 of a Valeant stock for each share they own.
Alex Parker

Novartis reshapes business by signing deals with GSK, Eli Lilly - 2 views

manufacturing.pharmaceutical-business-review.com/...h-gsk-eli-lilly-220414-4218360

health treatment foods generic

shared by Alex Parker on 23 Apr 14 - No Cached
  • Alex Parker on 23 Apr 14
     
    PBR Staff Writer Published 22 April 2014 Swiss pharmaceutical firm Novartis has entered into a definitive agreement to acquire the oncology unit of Britain's GlaxoSmithKline (GSK) for about $14.5bn and up to $1.5bn contingent on a development milestone. As part of the deal, Novartis would have opt-in rights to GSK's current and future oncology R&D pipeline.
Alex Parker

FDA approves GSK's Incruse Ellipta to treat airflow obstruction in COPD patients - 1 views

regulatoryaffairs.pharmaceutical-business-review.com/...n-copd-patients-010514-4256177

health foods treatment

shared by Alex Parker on 01 May 14 - No Cached
  • Alex Parker on 01 May 14
     
    PBR Staff Writer Published 01 May 2014 The US Food and Drug Administration (FDA) has approved GlaxoSmithKline's (GSK) Incruse Ellipta (umeclidinium) for the treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. Umeclidinium is a once-daily long-acting muscarinic antagonist (LAMA), a type of bronchodilator also known as an anticholinergic.
Alex Parker

ACETO completes acquisition of PACK Pharmaceuticals - 1 views

otc.pharmaceutical-business-review.com/...pharmaceuticals-010514-4256158

health foods

shared by Alex Parker on 01 May 14 - No Cached
  • Alex Parker on 01 May 14
     
    Published 01 May 2014 ACETO has announced that its wholly-owned subsidiary, Rising Pharmaceutical, has closed the acquisition of 100% of the equity interests of PACK Pharmaceuticals, a national marketer and distributor of generic prescription and over-the-counter pharmaceutical products. The total transaction value is approximately $100m.
Alex Parker

MabVax Therapeutics and Telik sign definitive merger agreement - 1 views

drugdiscovery.pharmaceutical-business-review.com/...erger-agreement-130514-4265439

health foods

shared by Alex Parker on 13 May 14 - No Cached
  • Alex Parker on 13 May 14
     
    MabVax Therapeutics and Telik sign definitive merger agreement
Alex Parker

KYTHERA files NDA for ATX-101 to reduce unwanted submental fat - 1 views

drugdelivery.pharmaceutical-business-review.com/...d-submental-fat-130514-4265243

health treatment

shared by Alex Parker on 13 May 14 - No Cached
  • Alex Parker on 13 May 14
     
    US-based KYTHERA Biopharmaceuticals has submitted a new drug application (NDA) to the US Food and Drug Administration (FDA) for ATX-101 (deoxycholic acid) as an injectable treatment for the reduction of submental fat, which commonly presents as a double chin.
Alex Parker

FDA approves Xolair for treatment of chronic hives - 1 views

regulatoryaffairs.pharmaceutical-business-review.com/...f-chronic-hives-080514-4262167

health foods treatment

shared by Alex Parker on 08 May 14 - No Cached
  • Alex Parker on 08 May 14
     
    The US Food and Drug Administration (FDA) has now approved the use of Omalizumab, commercially known as Xolair, for the treatment of chronic hives
Alex Parker

Eisai announces launch of Fycompa in Netherlands - 1 views

manufacturing.pharmaceutical-business-review.com/...-in-netherlands-130514-4265421

health treatment

shared by Alex Parker on 13 May 14 - No Cached
  • Alex Parker on 13 May 14
     
    Fycompa (perampanel), the first in an entirely new class of treatment for partial onset seizures (the most common form of epilepsy), will be launched in the Netherlands on 13 May 2014.
« First ‹ Previous 321 - 340 of 379 Next › Last »
Showing 20▼ items per page